Sylvie Gregoire is Director of Diffusion Pharmaceuticals Inc.. Currently has a direct ownership of 1.48 Million shares of DFFN, which is worth approximately $13.7 Million. The most recent transaction as insider was on Nov 17, 2025, when has been sold 10,793 shares (Common Stock) at a price of $8.46 per share, resulting in proceeds of $91,308. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.48M
102.73% 3M change
102.73% 12M change
Total Value Held $13.7 Million

Sylvie Gregoire Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
BUY
Open market or private purchase
$91,308 $8.46 p/Share
10,793 Added 0.72%
1,484,078 Common Stock
Nov 14 2025
BUY
Open market or private purchase
$12,921 $7.57 p/Share
1,707 Added 0.12%
1,473,285 Common Stock
Nov 13 2025
BUY
Open market or private purchase
$33,396 $7.51 p/Share
4,447 Added 0.3%
1,471,578 Common Stock
Nov 12 2025
BUY
Open market or private purchase
$40,814 $7.35 p/Share
5,553 Added 0.38%
1,467,131 Common Stock
Nov 09 2023
SELL
Bona fide gift
-
10,000 Reduced 1.35%
732,039 Common Stock

Also insider at

PKI
PERKINELMER INC Healthcare
SG

Sylvie Gregoire

Director
Waltham, MA

Track Institutional and Insider Activities on DFFN

Follow Diffusion Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DFFN shares.

Notify only if

Insider Trading

Get notified when an Diffusion Pharmaceuticals Inc. insider buys or sells DFFN shares.

Notify only if

News

Receive news related to Diffusion Pharmaceuticals Inc.

Track Activities on DFFN